Johns Hopkins HIV Guide
Thalidomide
INDICATIONS
FDA
FDA
- Treatment and prevention of erythema nodosum leprosum (ENL)
- Treatment of multiple myeloma in combination with dexamethasone.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of idiopathic aphthous stomatitis or esophagitis
- Treatment of HIV-associated wasting
- Possible other uses: refractory prurigo nodularis and microsporidiosis (unresponsive to albendazole)
- Hypertrophic HSV lessions unresponsive to acyclovir, foscarnet, and cidofovir[1]
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 3, 2016
Citation
Smith, Janessa M, and Paul A Pham. "Thalidomide." Johns Hopkins HIV Guide, The Johns Hopkins University, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545201/0/Thalidomide.
Smith JM, Pham PA. Thalidomide. Johns Hopkins HIV Guide. The Johns Hopkins University; 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545201/0/Thalidomide. Accessed September 26, 2025.
Smith, J. M., & Pham, P. A. (2016). Thalidomide. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545201/0/Thalidomide
Smith JM, Pham PA. Thalidomide [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2016. [cited 2025 September 26]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545201/0/Thalidomide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Thalidomide
ID - 545201
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/09/03/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545201/0/Thalidomide
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
